We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$380M
AUM Growth
+$99.8M
Cap. Flow
+$109M
Cap. Flow %
28.71%
Top 10 Hldgs %
78.29%
Holding
68
New
23
Increased
13
Reduced
4
Closed
13

Sector Composition

1 Technology 18.97%
2 Healthcare 18.73%
3 Consumer Discretionary 10.05%
4 Communication Services 9.72%
5 Financials 3.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTV
1
DELISTED
DIRECTV COM STK (DE)
DTV
$37.7M 9.91%
434,586
+111,809
+35% +$9.62M
DRC
2
DELISTED
DRESSER-RAND GROUP INC
DRC
$37.6M 9.89%
460,207
+80,207
+21% +$6.53M
CBST
3
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$37.6M 9.89%
+373,372
New +$29M
TRW
4
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$37.4M 9.83%
+363,601
New +$37.1M
CFN
5
DELISTED
CAREFUSION CORPORATION
CFN
$37.1M 9.76%
+625,852
New +$36M
IRF
6
DELISTED
INTL RECTIFIER CORP
IRF
$34.2M 9%
+857,586
New +$34.1M
SIAL
7
DELISTED
SIGMA - ALDRICH CORP
SIAL
$30.8M 8.09%
224,286
-3,714
-2% -$505K
TWC
8
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$28.6M 7.53%
188,265
-2,969
-2% -$428K
ALLY icon
9
Ally Financial
ALLY
$14B
$9.76M 2.57%
413,171
+10,000
+2% +$226K
INFI
10
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6.92M 1.82%
409,715
+82,894
+25% +$1.21M
OREX
11
DELISTED
Orexigen Therapeutics, Inc.
OREX
$6.42M 1.69%
105,866
+36,502
+53% +$1.83M
ICPT
12
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.04M 1.59%
38,732
+28,856
+292% +$5.33M
NKTR icon
13
Nektar Therapeutics
NKTR
$2.31B
$5.4M 1.42%
23,228
+7,923
+52% +$1.69M
TMUS icon
14
T-Mobile US
TMUS
$208B
$5.32M 1.4%
197,457
-111,573
-36% -$3.08M
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.11M 1.08%
91,487
+41,443
+83% +$1.74M
MNTA
16
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.19M 0.84%
264,508
+92,155
+53% +$1.05M
AAPL icon
17
CALL
Apple
AAPL
$4.9T
-2,800
Closed -$76.2K
HPTX
18
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$1.77M 0.46%
73,653
+21,761
+42% +$491K
GOOG icon
19
Alphabet (Google) Class C
GOOG
$4.22T
$1.59M 0.42%
+60,165
New +$1.61M
C icon
20
Citigroup
C
$217B
$1.45M 0.38%
26,800
CRTO icon
21
Criteo
CRTO
$1.13B
$1.42M 0.37%
+35,000
New +$1.25M
NRF
22
DELISTED
NorthStar Realty Finance Corp.
NRF
$1.32M 0.35%
37,538
+20,038
+115% +$714K
DAL icon
23
Delta Air Lines
DAL
$55.4B
$984K 0.26%
20,000
+10,000
+100% +$421K
AAL icon
24
American Airlines Group
AAL
$9.91B
$938K 0.25%
+17,500
New +$754K
BKD icon
25
Brookdale Senior Living
BKD
$3.58B
$916K 0.24%
25,000
+10,000
+67% +$339K

Similar funds

Cheyne Capital Management (UK)'s Q4 2014 Portfolio in Review

As of Q4 2014, Cheyne Capital Management (UK) held 68 positions worth $380M, up 36% from $281M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Cheyne Capital Management (UK) deployed $109M of net new capital in Q4 2014, opening 23 new positions and adding to 13 existing holdings. Its largest new stake was TRW AUTOMOTIVE HOLDINGS CORP: 363,601 shares worth $37.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $3.08M trimmed.

  • Cheyne Capital Management (UK)'s largest Q4 2014 buy was TRW AUTOMOTIVE HOLDINGS CORP: 363,601 shares worth $37.4M.
  • Cheyne Capital Management (UK) added most to DIRECTV COM STK (DE) in Q4 2014, an estimated $9.62M increase.
  • Cheyne Capital Management (UK)'s biggest Q4 2014 reduction was T-Mobile US, cutting an estimated $3.08M.
  • Cheyne Capital Management (UK) fully exited FOSTER WHEELER AG (SWITZERLAND) in Q4 2014, selling an estimated $29.7M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 78% of its $380M portfolio in Q4 2014.
  • Cheyne Capital Management (UK) opened 23 new positions and closed 13 in Q4 2014.
  • Cheyne Capital Management (UK)'s portfolio value rose 36% quarter-over-quarter to $380M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2014, filed 11 Feb 2015.